Asia-Pacific Friedreich Ataxia Drug Market Report 2018

2018-06-13 / 4000.00 / Pharma & Healthcare / 112 Pages

Description

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Friedreich Ataxia Drug for these regions, from 2012 to 2023 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Friedreich Ataxia Drug market competition by top manufacturers/players, with Friedreich Ataxia Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Adverum Biotechnologies Inc
BioMarin Pharmaceutical Inc.
Biovista Inc.
Cardero Therapeutics Inc
Catabasis Pharmaceuticals, Inc.
Forward Pharma A/S
Ixchel Pharma LLC
Pfizer Inc
ProQR Therapeutics NV
RaNA Therapeutics Inc
Reata Pharmaceuticals Inc
Retrotope Inc
Shire Plc
STATegics Inc
Voyager Therapeutics Inc

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
ADVM-063
AGIL-FA
BHV-4157
BVA-202
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Friedreich Ataxia Drug for each application, including
Clinic
Hospital
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Content

Table of Contents

Asia-Pacific Friedreich Ataxia Drug Market Report 2012-2023
1 Friedreich Ataxia Drug Overview
1.1 Product Overview and Scope of Friedreich Ataxia Drug
1.2 Classification of Friedreich Ataxia Drug by Product Category
1.2.1 Asia-Pacific Friedreich Ataxia Drug Sales (K Units) Comparison by Types (2012-2023)
1.2.2 Asia-Pacific Friedreich Ataxia Drug Sales (K Units) Market Share by Types in 2017
1.2.3 ADVM-063
1.2.4 AGIL-FA
1.2.5 BHV-4157
1.2.6 BVA-202
1.2.7 Others
1.3 Asia-Pacific Friedreich Ataxia Drug Market by Application/End Users
1.3.1 Asia-Pacific Friedreich Ataxia Drug (K Units) and Market Share Comparison by Applications (2012-2023)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Asia-Pacific Friedreich Ataxia Drug Market by Region
1.4.1 Asia-Pacific Friedreich Ataxia Drug Revenue (Million USD) Comparison by Regions (2012-2023)
1.4.2 China Status and Prospect (2012-2023)
1.4.3 Japan Status and Prospect (2012-2023)
1.4.4 South Korea Status and Prospect (2012-2023)
1.4.5 Taiwan Status and Prospect (2012-2023)
1.4.6 India Status and Prospect (2012-2023)
1.4.7 Southeast Asia Status and Prospect (2012-2023)
1.4.8 Australia Status and Prospect (2012-2023)
1.5 Asia-Pacific Sales and Revenue ofSales and Revenue of Friedreich Ataxia Drug (2012-2023)
1.5.1 Asia-Pacific Friedreich Ataxia Drug Sales (K Units) and Growth Rate (2012-2023)
1.5.2 Asia-Pacific Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (2012-2023)

2 Industrial Chain Analysis
2.1 Industry Chain Structure of Friedreich Ataxia Drug
2.2 Raw Material Analysis of Friedreich Ataxia Drug
2.1.1 Raw Material A Market Analysis
2.1.2 Raw Material B Market Analysis
2.1.3 Raw Material C Market Analysis
2.3 Labor Cost Analysis of K Units
2.4 Other Costs Analysis of Friedreich Ataxia Drug
2.5 Manufacturing Cost Structure Analysis of Friedreich Ataxia Drug
2.6 Manufacturing Process Analysis of Friedreich Ataxia Drug
2.7 Raw Materials Sources of Friedreich Ataxia Drug Major Manufacturers in 2018
2.8 Downstream Buyers

3 Asia-Pacific Friedreich Ataxia Drug Players/Suppliers Profiles and Sales Data
3.1 Adverum Biotechnologies Inc
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Friedreich Ataxia Drug Product Category, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.1.4 Adverum Biotechnologies Inc Different Types of Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.1.5 Adverum Biotechnologies Inc Friedreich Ataxia Drug Volume in Different Applications and Its Application Share
3.2 BioMarin Pharmaceutical Inc.
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Friedreich Ataxia Drug Product Category, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.2.4 BioMarin Pharmaceutical Inc. Different Types of Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.2.5 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Volume in Different Applications and Its Application Share
3.3 Biovista Inc.
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Friedreich Ataxia Drug Product Category, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Biovista Inc. Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.3.4 Biovista Inc. Different Types of Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.3.5 Biovista Inc. Friedreich Ataxia Drug Volume in Different Applications and Its Application Share
3.4 Cardero Therapeutics Inc
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Friedreich Ataxia Drug Product Category, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 Cardero Therapeutics Inc Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.4.4 Cardero Therapeutics Inc Different Types of Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.4.5 Cardero Therapeutics Inc Friedreich Ataxia Drug Volume in Different Applications and Its Application Share
3.5 Catabasis Pharmaceuticals, Inc.
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Friedreich Ataxia Drug Product Category, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.5.4 Catabasis Pharmaceuticals, Inc. Different Types of Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.5.5 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Volume in Different Applications and Its Application Share
3.6 Forward Pharma A/S
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Friedreich Ataxia Drug Product Category, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 Forward Pharma A/S Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.6.4 Forward Pharma A/S Different Types of Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.6.5 Forward Pharma A/S Friedreich Ataxia Drug Volume in Different Applications and Its Application Share
3.7 Ixchel Pharma LLC
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Friedreich Ataxia Drug Product Category, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 Ixchel Pharma LLC Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.7.4 Ixchel Pharma LLC Different Types of Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.7.5 Ixchel Pharma LLC Friedreich Ataxia Drug Volume in Different Applications and Its Application Share
3.8 Pfizer Inc
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Friedreich Ataxia Drug Product Category, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 Pfizer Inc Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.8.4 Pfizer Inc Different Types of Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.8.5 Pfizer Inc Friedreich Ataxia Drug Volume in Different Applications and Its Application Share
3.9 ProQR Therapeutics NV
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Friedreich Ataxia Drug Product Category, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 ProQR Therapeutics NV Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.9.4 ProQR Therapeutics NV Different Types of Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.9.5 ProQR Therapeutics NV Friedreich Ataxia Drug Volume in Different Applications and Its Application Share
3.10 RaNA Therapeutics Inc
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Friedreich Ataxia Drug Product Category, Application and Specification
3.10.2.1 Product A
3.10.2.2 Product B
3.10.3 RaNA Therapeutics Inc Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.10.4 RaNA Therapeutics Inc Different Types of Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.10.5 RaNA Therapeutics Inc Friedreich Ataxia Drug Volume in Different Applications and Its Application Share
3.11 Reata Pharmaceuticals Inc
3.12 Retrotope Inc
3.13 Shire Plc
3.14 STATegics Inc
3.15 Voyager Therapeutics Inc

4 Asia-Pacific Friedreich Ataxia Drug Competition by Players/Manufacturers, Region, Type and Application
4.1 Asia-Pacific Friedreich Ataxia Drug Market Competition by Players/Manufacturers
4.1.1 Asia-Pacific Friedreich Ataxia Drug Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017)
4.1.2 Asia-Pacific Friedreich Ataxia Drug Revenue (Million USD) and Share by Players/Suppliers (2012-2017)
4.2 Asia-Pacific Friedreich Ataxia Drug Sales and Revenue by Type
4.2.1 Asia-Pacific Friedreich Ataxia Drug Sales (K Units) and Market Share by Type (2012-2017)
4.2.2 Asia-Pacific Friedreich Ataxia Drug Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 Asia-Pacific Friedreich Ataxia Drug Sales and Revenue by Application
4.3.1 Asia-Pacific Friedreich Ataxia Drug Sales (K Units) and Market Share by Regions (2012-2017)
4.3.2 Asia-Pacific Friedreich Ataxia Drug Revenue (Million USD) and Market Share (%) Regions (2012-2017)
4.4 Asia-Pacific Friedreich Ataxia Drug Sales (K Units) by Application

5 China Friedreich Ataxia Drug (Sales, Revenue and Price)
5.1 China Friedreich Ataxia Drug Sales and Value (2012-2017)
5.1.1 China Friedreich Ataxia Drug Sales (K Units) and Growth Rate (2012-2017)
5.1.2 China Friedreich Ataxia Drug Revenue and Growth Rate (2012-2017)
5.1.3 China Friedreich Ataxia Drug Sales Price (USD/Unit) Trend (2012-2017)
5.2 China Friedreich Ataxia Drug Sales (K Units) and Market Share by Type
5.3 China Friedreich Ataxia Drug Sales (K Units) and Market Share by Application

6 Japan Friedreich Ataxia Drug (Sales, Revenue and Price)
6.1 Japan Friedreich Ataxia Drug Sales and Value (2012-2017)
6.1.1 Japan Friedreich Ataxia Drug Sales (K Units) and Growth Rate (2012-2017)
6.1.2 Japan Friedreich Ataxia Drug Revenue and Growth Rate (2012-2017)
6.1.3 Japan Friedreich Ataxia Drug Sales Price (USD/Unit) Trend (2012-2017)
6.2 Japan Friedreich Ataxia Drug Sales (K Units) and Market Share by Type
6.3 Japan Friedreich Ataxia Drug Sales (K Units) and Market Share by Application

7 South Korea Friedreich Ataxia Drug (Sales, Revenue and Price)
7.1 South Korea Friedreich Ataxia Drug Sales and Value (2012-2017)
7.1.1 South Korea Friedreich Ataxia Drug Sales (K Units) and Growth Rate (2012-2017)
7.1.2 South Korea Friedreich Ataxia Drug Revenue and Growth Rate (2012-2017)
7.1.3 South Korea Friedreich Ataxia Drug Sales Price (USD/Unit) Trend (2012-2017)
7.2 South Korea Friedreich Ataxia Drug Sales (K Units) and Market Share by Type
7.3 South Korea Friedreich Ataxia Drug Sales (K Units) and Market Share by Application

8 Taiwan Friedreich Ataxia Drug (Sales, Revenue and Price)
8.1 Taiwan Friedreich Ataxia Drug Sales and Value (2012-2017)
8.1.1 Taiwan Friedreich Ataxia Drug Sales (K Units) and Growth Rate (2012-2017)
8.1.2 Taiwan Friedreich Ataxia Drug Revenue and Growth Rate (2012-2017)
8.1.3 Taiwan Friedreich Ataxia Drug Sales Price (USD/Unit) Trend (2012-2017)
8.2 Taiwan Friedreich Ataxia Drug Sales (K Units) and Market Share by Type
8.3 Taiwan Friedreich Ataxia Drug Sales (K Units) and Market Share by Application

9 India Friedreich Ataxia Drug (Sales, Revenue and Price)
9.1 India Friedreich Ataxia Drug Sales and Value (2012-2017)
9.1.1 India Friedreich Ataxia Drug Sales (K Units) and Growth Rate (2012-2017)
9.1.2 India Friedreich Ataxia Drug Revenue and Growth Rate (2012-2017)
9.1.3 India Friedreich Ataxia Drug Sales Price (USD/Unit) Trend (2012-2017)
9.2 India Friedreich Ataxia Drug Sales (K Units) and Market Share by Type
9.3 India Friedreich Ataxia Drug Sales (K Units) and Market Share by Application

10 Southeast Asia Friedreich Ataxia Drug (Sales, Revenue and Price)
10.1 Southeast Asia Friedreich Ataxia Drug Sales and Value (2012-2017)
10.1.1 Southeast Asia Friedreich Ataxia Drug Sales (K Units) and Growth Rate (2012-2017)
10.1.2 Southeast Asia Friedreich Ataxia Drug Revenue and Growth Rate (2012-2017)
10.1.3 Southeast Asia Friedreich Ataxia Drug Sales Price (USD/Unit) Trend (2012-2017)
10.2 Southeast Asia Friedreich Ataxia Drug Sales (K Units) and Market Share by Type
10.3 Southeast Asia Friedreich Ataxia Drug Sales (K Units) and Market Share by Application

11 Australia Friedreich Ataxia Drug (Sales, Revenue and Price)
11.1 Australia Friedreich Ataxia Drug Sales and Value (2012-2017)
11.1.1 Australia Friedreich Ataxia Drug Sales (K Units) and Growth Rate (2012-2017)
11.1.2 Australia Friedreich Ataxia Drug Revenue and Growth Rate (2012-2017)
11.1.3 Australia Friedreich Ataxia Drug Sales Price (USD/Unit) Trend (2012-2017)
11.2 Australia Friedreich Ataxia Drug Sales (K Units) and Market Share by Type
11.3 Australia Friedreich Ataxia Drug Sales (K Units) and Market Share by Application

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Direct Marketing
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Asia-Pacific Friedreich Ataxia Drug Market Forecast (2018-2023)
13.1 Asia-Pacific Friedreich Ataxia Drug Sales (K Units), Revenue and Price Forecast (2018-2023)
13.1.1 Asia-Pacific Friedreich Ataxia Drug Sales (K Units) and Growth Rate Forecast (2018-2023)
13.1.2 Asia-Pacific Friedreich Ataxia Drug Revenue and Growth Rate Forecast (2018-2023)
13.1.3 Asia-Pacific Friedreich Ataxia Drug Price and Trend Forecast (2018-2023)
13.2 Asia-Pacific Friedreich Ataxia Drug Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023)
13.2.1 Asia-Pacific Friedreich Ataxia Drug Sales (K Units) and Growth Rate Forecast by Region (2018-2023)
13.2.2 Asia-Pacific Friedreich Ataxia Drug Revenue and Growth Rate Forecast by Region (2018-2023)
13.2.3 China Friedreich Ataxia Drug Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.4 Japan Friedreich Ataxia Drug Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.5 South Korea Friedreich Ataxia Drug Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.6 Taiwan Friedreich Ataxia Drug Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.7 South Korea Friedreich Ataxia Drug Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.8 Southeast Asia Friedreich Ataxia Drug Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.9 Australia Friedreich Ataxia Drug Sales, Revenue and Growth Rate Forecast (2018-2023)
13.3 Asia-Pacific Friedreich Ataxia Drug Sales, Revenue and Price Forecast by Type (2018-2023)
13.3.1 Asia-Pacific Friedreich Ataxia Drug Sales Forecast by Type (2018-2023)
13.3.2 Asia-Pacific Friedreich Ataxia Drug Revenue Forecast by Type (2018-2023)
13.3.3 Asia-Pacific Friedreich Ataxia Drug Price Forecast by Type (2018-2023)
13.4 Asia-Pacific Friedreich Ataxia Drug Sales Forecast by Application (2018-2023)

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Disclaimer



Table of Figures

List of Tables and Figures

Figure Asia-Pacific Market Size (Million USD) Comparison 2012-2023
Table Asia-Pacific Market Friedreich Ataxia Drug Revenue (Million USD) Comparison by Regions 2012-2023
Table Asia-Pacific Friedreich Ataxia Drug Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Asia-Pacific Friedreich Ataxia Drug Sales (K Units) by Application (2016-2023)
Figure Product Picture of Friedreich Ataxia Drug
Table Asia-Pacific Friedreich Ataxia Drug Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023)
Figure Asia-Pacific Friedreich Ataxia Drug Sales (K Units) Market Share by Types in 2017
Figure ADVM-063 Picture
Figure AGIL-FA Picture
Figure BHV-4157 Picture
Table Asia-Pacific Friedreich Ataxia Drug Sales (K Units) Comparison by Applications (2012-2023)
Figure Asia-Pacific Sales Market Share of Friedreich Ataxia Drug by Applications in 2017
Figure Clinic Picture
Figure Hospital Picture
Figure Others Picture
Table Asia-Pacific Market Friedreich Ataxia Drug Revenue (Million USD) Comparison by Regions 2012-2023
Figure China Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (2012-2023)
Figure Japan Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (2012-2023)
Figure South Korea Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (2012-2023)
Figure Taiwan Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (2012-2023)
Figure India Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (2012-2023)
Figure Southeast Asia Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (2012-2023)
Figure Australia Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (2012-2023)
Figure Asia-Pacific Friedreich Ataxia Drug Sales (K Units) and Growth Rate (2012-2023)
Figure Asia-Pacific Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (2012-2023)
Figure New Project SWOT Analysis of Friedreich Ataxia Drug
Table Industry News List of Friedreich Ataxia Drug
Figure Industry Chain Structure of Friedreich Ataxia Drug
Table Raw Material Suppliers and Price Analysis
Figure Global Raw Material A Price Trend (USD/MT)
Figure Global Raw Material B Price Trend (USD/MT)
Figure Global Raw Material C Price Trend (USD/MT)
Table Manufacturing Cost Structure Analysis of Friedreich Ataxia Drug in 2017
Figure Manufacturing Process Analysis of Friedreich Ataxia Drug
Table Raw Materials Sources of Friedreich Ataxia Drug Major Manufacturers in 2017
Table Major Buyers of Friedreich Ataxia Drug
Table Adverum Biotechnologies Inc Basic Information List
Table Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales Growth Rate (2012-2017)
Figure Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales Asia-Pacific Market Share (%) (2012-2017)
Figure Adverum Biotechnologies Inc Friedreich Ataxia Drug Revenue Asia-Pacific Market Share (%) (2012-2017)
Table ADVM-063 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table AGIL-FA Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table BHV-4157 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Adverum Biotechnologies Inc Friedreich Ataxia Drug Volume in Clinic and Its Application Share
Table Adverum Biotechnologies Inc Friedreich Ataxia Drug Volume in Hospital and Its Application Share
Table Adverum Biotechnologies Inc Friedreich Ataxia Drug Volume in Others and Its Application Share
Table BioMarin Pharmaceutical Inc. Basic Information List
Table BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales Growth Rate (2012-2017)
Figure BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales Asia-Pacific Market Share (%) (2012-2017)
Figure BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Revenue Asia-Pacific Market Share (%) (2012-2017)
Table ADVM-063 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table AGIL-FA Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table BHV-4157 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Volume in Clinic and Its Application Share
Table BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Volume in Hospital and Its Application Share
Table BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Volume in Others and Its Application Share
Table Biovista Inc. Basic Information List
Table Biovista Inc. Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Biovista Inc. Friedreich Ataxia Drug Sales Growth Rate (2012-2017)
Figure Biovista Inc. Friedreich Ataxia Drug Sales Asia-Pacific Market Share (%) (2012-2017)
Figure Biovista Inc. Friedreich Ataxia Drug Revenue Asia-Pacific Market Share (%) (2012-2017)
Table ADVM-063 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table AGIL-FA Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table BHV-4157 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Biovista Inc. Friedreich Ataxia Drug Volume in Clinic and Its Application Share
Table Biovista Inc. Friedreich Ataxia Drug Volume in Hospital and Its Application Share
Table Biovista Inc. Friedreich Ataxia Drug Volume in Others and Its Application Share
Table Cardero Therapeutics Inc Basic Information List
Table Cardero Therapeutics Inc Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Cardero Therapeutics Inc Friedreich Ataxia Drug Sales Growth Rate (2012-2017)
Figure Cardero Therapeutics Inc Friedreich Ataxia Drug Sales Asia-Pacific Market Share (%) (2012-2017)
Figure Cardero Therapeutics Inc Friedreich Ataxia Drug Revenue Asia-Pacific Market Share (%) (2012-2017)
Table ADVM-063 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table AGIL-FA Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table BHV-4157 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Cardero Therapeutics Inc Friedreich Ataxia Drug Volume in Clinic and Its Application Share
Table Cardero Therapeutics Inc Friedreich Ataxia Drug Volume in Hospital and Its Application Share
Table Cardero Therapeutics Inc Friedreich Ataxia Drug Volume in Others and Its Application Share
Table Catabasis Pharmaceuticals, Inc. Basic Information List
Table Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales Growth Rate (2012-2017)
Figure Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales Asia-Pacific Market Share (%) (2012-2017)
Figure Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Revenue Asia-Pacific Market Share (%) (2012-2017)
Table ADVM-063 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table AGIL-FA Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table BHV-4157 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Volume in Clinic and Its Application Share
Table Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Volume in Hospital and Its Application Share
Table Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Volume in Others and Its Application Share
Table Forward Pharma A/S Basic Information List
Table Forward Pharma A/S Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Forward Pharma A/S Friedreich Ataxia Drug Sales Growth Rate (2012-2017)
Figure Forward Pharma A/S Friedreich Ataxia Drug Sales Asia-Pacific Market Share (%) (2012-2017)
Figure Forward Pharma A/S Friedreich Ataxia Drug Revenue Asia-Pacific Market Share (%) (2012-2017)
Table ADVM-063 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table AGIL-FA Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table BHV-4157 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Forward Pharma A/S Friedreich Ataxia Drug Volume in Clinic and Its Application Share
Table Forward Pharma A/S Friedreich Ataxia Drug Volume in Hospital and Its Application Share
Table Forward Pharma A/S Friedreich Ataxia Drug Volume in Others and Its Application Share
Table Ixchel Pharma LLC Basic Information List
Table Ixchel Pharma LLC Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Ixchel Pharma LLC Friedreich Ataxia Drug Sales Growth Rate (2012-2017)
Figure Ixchel Pharma LLC Friedreich Ataxia Drug Sales Asia-Pacific Market Share (%) (2012-2017)
Figure Ixchel Pharma LLC Friedreich Ataxia Drug Revenue Asia-Pacific Market Share (%) (2012-2017)
Table ADVM-063 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table AGIL-FA Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table BHV-4157 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Ixchel Pharma LLC Friedreich Ataxia Drug Volume in Clinic and Its Application Share
Table Ixchel Pharma LLC Friedreich Ataxia Drug Volume in Hospital and Its Application Share
Table Ixchel Pharma LLC Friedreich Ataxia Drug Volume in Others and Its Application Share
Table Pfizer Inc Basic Information List
Table Pfizer Inc Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Pfizer Inc Friedreich Ataxia Drug Sales Growth Rate (2012-2017)
Figure Pfizer Inc Friedreich Ataxia Drug Sales Asia-Pacific Market Share (%) (2012-2017)
Figure Pfizer Inc Friedreich Ataxia Drug Revenue Asia-Pacific Market Share (%) (2012-2017)
Table ADVM-063 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table AGIL-FA Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table BHV-4157 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Pfizer Inc Friedreich Ataxia Drug Volume in Clinic and Its Application Share
Table Pfizer Inc Friedreich Ataxia Drug Volume in Hospital and Its Application Share
Table Pfizer Inc Friedreich Ataxia Drug Volume in Others and Its Application Share
Table ProQR Therapeutics NV Basic Information List
Table ProQR Therapeutics NV Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure ProQR Therapeutics NV Friedreich Ataxia Drug Sales Growth Rate (2012-2017)
Figure ProQR Therapeutics NV Friedreich Ataxia Drug Sales Asia-Pacific Market Share (%) (2012-2017)
Figure ProQR Therapeutics NV Friedreich Ataxia Drug Revenue Asia-Pacific Market Share (%) (2012-2017)
Table ADVM-063 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table AGIL-FA Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table BHV-4157 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table ProQR Therapeutics NV Friedreich Ataxia Drug Volume in Clinic and Its Application Share
Table ProQR Therapeutics NV Friedreich Ataxia Drug Volume in Hospital and Its Application Share
Table ProQR Therapeutics NV Friedreich Ataxia Drug Volume in Others and Its Application Share
Table Company RaNA Therapeutics Inc Basic Information List
Table Company RaNA Therapeutics Inc Friedreich Ataxia Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Company RaNA Therapeutics Inc Friedreich Ataxia Drug Sales Growth Rate (2012-2017)
Figure Company RaNA Therapeutics Inc Friedreich Ataxia Drug Sales Asia-Pacific Market Share (%) (2012-2017)
Figure Company RaNA Therapeutics Inc Friedreich Ataxia Drug Revenue Asia-Pacific Market Share (%) (2012-2017)
Table ADVM-063 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table AGIL-FA Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table BHV-4157 Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
Table Company RaNA Therapeutics Inc Friedreich Ataxia Drug Volume in Clinic and Its Application Share
Table Company RaNA Therapeutics Inc Friedreich Ataxia Drug Volume in Hospital and Its Application Share
Table Company RaNA Therapeutics Inc Friedreich Ataxia Drug Volume in Others and Its Application Share
Table Asia-Pacific Friedreich Ataxia Drug Sales (K Units) by Players/Manufacturers (2012-2017)
Table Asia-Pacific Friedreich Ataxia Drug Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 Asia-Pacific Friedreich Ataxia Drug Sales Market Share (%) by Players/Manufacturers
Figure 2017 Asia-Pacific Friedreich Ataxia Drug Sales Share by Players/Manufacturers
Table Asia-Pacific Friedreich Ataxia Drug Revenue (Million USD) by Players/Manufacturers (2012-2017)
Table Asia-Pacific Friedreich Ataxia Drug Revenue Market Share (%) Players/Manufacturers (2012-2017)
Figure 2016 Asia-Pacific Friedreich Ataxia Drug Revenue Market Share (%) Players
Figure 2017 Asia-Pacific Friedreich Ataxia Drug Revenue Market Share (%) Players
Table Asia-Pacific Friedreich Ataxia Drug Sales (K Units) and Market Share (%) by Type (2012-2017)
Table Asia-Pacific Friedreich Ataxia Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Friedreich Ataxia Drug by Type (2012-2017)
Figure Asia-Pacific Friedreich Ataxia Drug Sales Growth Rate (%) by Type (2012-2017)
Table Asia-Pacific Friedreich Ataxia Drug Revenue (Million USD) and Market Share (%) Type (2012-2017)
Table Asia-Pacific Friedreich Ataxia Drug Revenue Market Share (%) Type (2012-2017)
Figure Revenue Market Share of Friedreich Ataxia Drug by Type (2012-2017)
Figure Asia-Pacific Friedreich Ataxia Drug Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Friedreich Ataxia Drug Sales (K Units) and Market Share by Regions (2012-2017)
Table Asia-Pacific Friedreich Ataxia Drug Sales Share by Regions (2012-2017)
Figure Sales Market Share of Friedreich Ataxia Drug by Regions (2012-2017)
Figure Asia-Pacific Friedreich Ataxia Drug Sales Market Share by Regions in 2017
Table Asia-Pacific Friedreich Ataxia Drug Revenue (Million USD) and Market Share by Regions (2012-2017)
Table Asia-Pacific Friedreich Ataxia Drug Revenue Share (%) by Regions (2012-2017)
Figure Revenue Market Share of Friedreich Ataxia Drug by Regions (2012-2017)
Figure Asia-Pacific Friedreich Ataxia Drug Revenue Market Share by Regions in 2017
Table Asia-Pacific Friedreich Ataxia Drug Sales (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Friedreich Ataxia Drug Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Friedreich Ataxia Drug Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Friedreich Ataxia Drug Sales Market Share by Application (2012-2017)
Figure China Friedreich Ataxia Drug Sales (K Units) and Growth Rate (%) (2012-2017)
Figure China Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure China Friedreich Ataxia Drug Sales Price (USD/Unit) Trend (2012-2017)
Table China Friedreich Ataxia Drug Sales (K Units) by Type (2012-2017)
Table China Friedreich Ataxia Drug Sales (K Units) Market Share by Type (2012-2017)
Figure China Friedreich Ataxia Drug Sales (K Units) Market Share by Type in 2017
Table China Friedreich Ataxia Drug Sales (K Units) by Applications (2012-2017)
Table China Friedreich Ataxia Drug Sales (K Units) Market Share by Applications (2012-2017)
Figure China Friedreich Ataxia Drug Sales (K Units) Market Share by Applications in 2017
Figure Japan Friedreich Ataxia Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Japan Friedreich Ataxia Drug Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Friedreich Ataxia Drug Sales (K Units) by Type (2012-2017)
Table Japan Friedreich Ataxia Drug Sales (K Units) Market Share by Type (2012-2017)
Figure Japan Friedreich Ataxia Drug Sales (K Units) Market Share by Type in 2017
Table Japan Friedreich Ataxia Drug Sales (K Units) by Applications (2012-2017)
Table Japan Friedreich Ataxia Drug Sales (K Units) Market Share by Applications (2012-2017)
Figure Japan Friedreich Ataxia Drug Sales (K Units) Market Share by Applications in 2017
Figure South Korea Friedreich Ataxia Drug Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure South Korea Friedreich Ataxia Drug Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Friedreich Ataxia Drug Sales (K Units) by Type (2012-2017)
Table South Korea Friedreich Ataxia Drug Sales (K Units) Market Share by Type (2012-2017)
Figure South Korea Friedreich Ataxia Drug Sales (K Units) Market Share by Type in 2017
Table South Korea Friedreich Ataxia Drug Sales (K Units) by Applications (2012-2017)
Table South Korea Friedreich Ataxia Drug Sales (K Units) Market Share by Applications (2012-2017)
Figure South Korea Friedreich Ataxia Drug Sales (K Units) Market Share by Applications in 2017
Figure Taiwan Friedreich Ataxia Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Taiwan Friedreich Ataxia Drug Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Friedreich Ataxia Drug Sales (K Units) by Type (2012-2017)
Table Taiwan Friedreich Ataxia Drug Sales (K Units) Market Share by Type (2012-2017)
Figure Taiwan Friedreich Ataxia Drug Sales (K Units) Market Share by Type in 2017
Table Taiwan Friedreich Ataxia Drug Sales (K Units) by Applications (2012-2017)
Table Taiwan Friedreich Ataxia Drug Sales (K Units) Market Share by Applications (2012-2017)
Figure Taiwan Friedreich Ataxia Drug Sales (K Units) Market Share by Applications in 2017
Figure Southeast Asia Friedreich Ataxia Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Southeast Asia Friedreich Ataxia Drug Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Friedreich Ataxia Drug Sales (K Units) by Type (2012-2017)
Table Southeast Asia Friedreich Ataxia Drug Sales (K Units) Market Share by Type (2012-2017)
Figure Southeast Asia Friedreich Ataxia Drug Sales (K Units) Market Share by Type in 2017
Table Southeast Asia Friedreich Ataxia Drug Sales (K Units) by Applications (2012-2017)
Table Southeast Asia Friedreich Ataxia Drug Sales (K Units) Market Share by Applications (2012-2017)
Figure Southeast Asia Friedreich Ataxia Drug Sales (K Units) Market Share by Applications in 2017
Figure India Friedreich Ataxia Drug Sales (K Units) and Growth Rate (2012-2017)
Figure India Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure India Friedreich Ataxia Drug Sales Price (USD/Unit) Trend (2012-2017)
Table India Friedreich Ataxia Drug Sales (K Units) by Type (2012-2017)
Table India Friedreich Ataxia Drug Sales (K Units) Market Share by Type (2012-2017)
Figure India Friedreich Ataxia Drug Sales (K Units) Market Share by Type in 2017
Table India Friedreich Ataxia Drug Sales (K Units) by Applications (2012-2017)
Table India Friedreich Ataxia Drug Sales (K Units) Market Share by Applications (2012-2017)
Figure India Friedreich Ataxia Drug Sales (K Units) Market Share by Applications in 2017
Figure Australia Friedreich Ataxia Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Australia Friedreich Ataxia Drug Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Friedreich Ataxia Drug Sales (K Units) by Type (2012-2017)
Table Australia Friedreich Ataxia Drug Sales (K Units) Market Share by Type (2012-2017)
Figure Australia Friedreich Ataxia Drug Sales (K Units) Market Share by Type in 2017
Table Australia Friedreich Ataxia Drug Sales (K Units) by Applications (2012-2017)
Table Australia Friedreich Ataxia Drug Sales (K Units) Market Share by Applications (2012-2017)
Figure Australia Friedreich Ataxia Drug Sales (K Units) Market Share by Applications in 2017
Table Distributors/Traders List
Figure Asia-Pacific Friedreich Ataxia Drug Sales (K Units) and Growth Rate Forecast (2018-2023)
Figure Asia-Pacific Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Asia-Pacific Friedreich Ataxia Drug Price and Trend Forecast (2018-2023)
Table Asia-Pacific Friedreich Ataxia Drug Sales (K Units) Forecast by Regions (2018-2023)
Figure Asia-Pacific Friedreich Ataxia Drug Sales (K Units) Market Share Forecast by Regions (2018-2023)
Figure Asia-Pacific Friedreich Ataxia Drug Sales (K Units) Market Share Forecast by Regions in 2023
Table Asia-Pacific Friedreich Ataxia Drug Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Asia-Pacific Friedreich Ataxia Drug Revenue Market Share Forecast by Regions (2018-2023)
Figure Asia-Pacific Friedreich Ataxia Drug Revenue Market Share Forecast by Regions in 2023
Figure China Friedreich Ataxia Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure China Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure South Korea Friedreich Ataxia Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure South Korea Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Japan Friedreich Ataxia Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Japan Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Taiwan Friedreich Ataxia Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Taiwan Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure India Friedreich Ataxia Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure India Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Southeast Asia Friedreich Ataxia Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Southeast Asia Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Australia Friedreich Ataxia Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Australia Friedreich Ataxia Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Table Asia-Pacific Friedreich Ataxia Drug Sales (K Units) Forecast by Type (2018-2023)
Figure Asia-Pacific Friedreich Ataxia Drug Sales Market Share Forecast by Type (2018-2023)
Table Asia-Pacific Friedreich Ataxia Drug Revenue (Million USD) Forecast by Type (2018-2023)
Figure Asia-Pacific Friedreich Ataxia Drug Revenue Market Share Forecast by Type (2018-2023)
Table Asia-Pacific Friedreich Ataxia Drug Price (USD/Unit) Forecast by Type (2018-2023)
Table Asia-Pacific Friedreich Ataxia Drug Sales (K Units) Forecast by Application (2018-2023)
Figure Asia-Pacific Friedreich Ataxia Drug Sales Market Share Forecast by Application (2018-2023)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources






Request Sample

* mark fields are compulsory